417 related articles for article (PubMed ID: 7559790)
21. An enzyme trafficking defect in two patients with primary hyperoxaluria type 1: peroxisomal alanine/glyoxylate aminotransferase rerouted to mitochondria.
Danpure CJ; Cooper PJ; Wise PJ; Jennings PR
J Cell Biol; 1989 Apr; 108(4):1345-52. PubMed ID: 2925788
[TBL] [Abstract][Full Text] [Related]
22. Further studies on the activity and subcellular distribution of alanine:glyoxylate aminotransferase in the livers of patients with primary hyperoxaluria type 1.
Danpure CJ; Jennings PR
Clin Sci (Lond); 1988 Sep; 75(3):315-22. PubMed ID: 3416563
[TBL] [Abstract][Full Text] [Related]
23. ATP-dependent degradation of a mutant serine: pyruvate/alanine:glyoxylate aminotransferase in a primary hyperoxaluria type 1 case.
Nishiyama K; Funai T; Yokota S; Ichiyama A
J Cell Biol; 1993 Dec; 123(5):1237-48. PubMed ID: 8245128
[TBL] [Abstract][Full Text] [Related]
24. Alanine glyoxylate aminotransferase deficiency: biochemical and molecular genetic lessons from the study of a human disease.
Watts RW
Adv Enzyme Regul; 1992; 32():309-27. PubMed ID: 1496924
[TBL] [Abstract][Full Text] [Related]
25. A novel mutation of human liver alanine:glyoxylate aminotransferase causes primary hyperoxaluria type 1: immunohistochemical quantification and subcellular distribution.
Kawai C; Minatogawa Y; Akiyoshi H; Hirose S; Suehiro T; Tone S
Acta Histochem Cytochem; 2012 Apr; 45(2):121-9. PubMed ID: 22685354
[TBL] [Abstract][Full Text] [Related]
26. Abnormality in catalase import into peroxisomes leads to severe neurological disorder.
Sheikh FG; Pahan K; Khan M; Barbosa E; Singh I
Proc Natl Acad Sci U S A; 1998 Mar; 95(6):2961-6. PubMed ID: 9501198
[TBL] [Abstract][Full Text] [Related]
27. Correction of an enzyme trafficking defect in hereditary kidney stone disease in vitro.
Lumb MJ; Birdsey GM; Danpure CJ
Biochem J; 2003 Aug; 374(Pt 1):79-87. PubMed ID: 12737622
[TBL] [Abstract][Full Text] [Related]
28. Pharmacologic rescue of an enzyme-trafficking defect in primary hyperoxaluria 1.
Miyata N; Steffen J; Johnson ME; Fargue S; Danpure CJ; Koehler CM
Proc Natl Acad Sci U S A; 2014 Oct; 111(40):14406-11. PubMed ID: 25237136
[TBL] [Abstract][Full Text] [Related]
29. Characterization of peroxisomal targeting signals on alanine: glyoxylate aminotransferase.
Ikeda M; Kanouchi H; Minatogawa Y
Biol Pharm Bull; 2008 Jan; 31(1):131-4. PubMed ID: 18175955
[TBL] [Abstract][Full Text] [Related]
30. Alanine:glyoxylate aminotransferase peroxisome-to-mitochondrion mistargeting in human hereditary kidney stone disease.
Danpure CJ; Lumb MJ; Birdsey GM; Zhang X
Biochim Biophys Acta; 2003 Apr; 1647(1-2):70-5. PubMed ID: 12686111
[TBL] [Abstract][Full Text] [Related]
31. Molecular evolution of alanine/glyoxylate aminotransferase 1 intracellular targeting. Analysis of the feline gene.
Lumb MJ; Purdue PE; Danpure CJ
Eur J Biochem; 1994 Apr; 221(1):53-62. PubMed ID: 8168541
[TBL] [Abstract][Full Text] [Related]
32. Oxalate synthesis in mammals: properties and subcellular distribution of serine:pyruvate/alanine:glyoxylate aminotransferase in the liver.
Ichiyama A; Xue HH; Oda T; Uchida C; Sugiyama T; Maeda-Nakai E; Sato K; Nagai E; Watanabe S; Takayama T
Mol Urol; 2000; 4(4):333-40. PubMed ID: 11156700
[TBL] [Abstract][Full Text] [Related]
33. Translation inhibition corrects aberrant localization of mutant alanine-glyoxylate aminotransferase: possible therapeutic approach for hyperoxaluria.
Belostotsky R; Lyakhovetsky R; Sherman MY; Shkedy F; Tzvi-Behr S; Bar R; Hoppe B; Reusch B; Beck BB; Frishberg Y
J Mol Med (Berl); 2018 Jul; 96(7):621-630. PubMed ID: 29777253
[TBL] [Abstract][Full Text] [Related]
34. Molecular Insight into the Synergism between the Minor Allele of Human Liver Peroxisomal Alanine:Glyoxylate Aminotransferase and the F152I Mutation.
Cellini B; Montioli R; Paiardini A; Lorenzetto A; Voltattorni CB
J Biol Chem; 2009 Mar; 284(13):8349-58. PubMed ID: 19155213
[TBL] [Abstract][Full Text] [Related]
35. Human peroxisomal L-alanine: glyoxylate aminotransferase. Evolutionary loss of a mitochondrial targeting signal by point mutation of the initiation codon.
Takada Y; Kaneko N; Esumi H; Purdue PE; Danpure CJ
Biochem J; 1990 Jun; 268(2):517-20. PubMed ID: 2363689
[TBL] [Abstract][Full Text] [Related]
36. Peroxisomal and mitochondrial targeting of serine:pyruvate/alanine:glyoxylate aminotransferase in rat liver.
Oda T; Mizuno T; Ito K; Funai T; Ichiyama A; Miura S
Cell Biochem Biophys; 2000; 32 Spring():277-81. PubMed ID: 11330058
[TBL] [Abstract][Full Text] [Related]
37. Use of polymer conjugates for the intraperoxisomal delivery of engineered human alanine:glyoxylate aminotransferase as a protein therapy for primary hyperoxaluria type I.
Roncador A; Oppici E; Talelli M; Pariente AN; Donini M; Dusi S; Voltattorni CB; Vicent MJ; Cellini B
Nanomedicine; 2017 Apr; 13(3):897-907. PubMed ID: 27993722
[TBL] [Abstract][Full Text] [Related]
38. The pas8 mutant of Pichia pastoris exhibits the peroxisomal protein import deficiencies of Zellweger syndrome cells--the PAS8 protein binds to the COOH-terminal tripeptide peroxisomal targeting signal, and is a member of the TPR protein family.
McCollum D; Monosov E; Subramani S
J Cell Biol; 1993 May; 121(4):761-74. PubMed ID: 8098333
[TBL] [Abstract][Full Text] [Related]
39. A glycine-to-glutamate substitution abolishes alanine:glyoxylate aminotransferase catalytic activity in a subset of patients with primary hyperoxaluria type 1.
Purdue PE; Lumb MJ; Allsop J; Minatogawa Y; Danpure CJ
Genomics; 1992 May; 13(1):215-8. PubMed ID: 1349575
[TBL] [Abstract][Full Text] [Related]
40. Four of the most common mutations in primary hyperoxaluria type 1 unmask the cryptic mitochondrial targeting sequence of alanine:glyoxylate aminotransferase encoded by the polymorphic minor allele.
Fargue S; Lewin J; Rumsby G; Danpure CJ
J Biol Chem; 2013 Jan; 288(4):2475-84. PubMed ID: 23229545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
